Pharmacovigilance

In spite of the current farreaching tests, to which a medicine must be subjected before authorization, exceptionally risks may only be identified after the market launch when the product is in widespread application and everyday use. The cataloguing of spontaneous reports is still the best way to discover such problems early on.
You will find here all information about reporting the undesirable side-effects of medicines.

Contact

Swissmedic
Pharmacovigilance Centre
Hallerstrasse 7
P.O. Box
3000 Bern 9
Switzerland

+41 58 462 03 52
+41 58 462 04 18
vigilance@swissmedic.ch